Citations

Mayo Clinic

Showing 10 of 108523 citations.

Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
Al‐Hamadani, Mohammed , Macon, William R. , Go, Ronald S. , Go, Ronald S , Habermann, Thomas M. , Cerhan, James R. , Maurer, Matthew J.

American Journal of Hematology | June 19, 2015 | Volume: 90 | Issue: 9 | Pages: 790-795

10.1002/ajh.24086 | PMID 26096944 Get It

The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was introduced in 2001. However, its incorporation into clinical practice is not well‐described. We studied the distribution of NHL subtypes in adults diagnosed from 1998 to 2011, evaluated time trends, geo‐demographic correlates, and changes in 5‐year overall survival (OS). We obtained data prospectively collected by the National Cancer Data Base, which covers 70% of US cancer cases. There were 596,476 patients diagnosed with NHL. The major subtypes were diffuse large B‐cell (32.5%), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL; 18.6%), follicular (17.1%), marginal zone (8.3%), mantle cell (4.1%), peripheral T‐cell not‐otherwise‐specified (1.7%), Burkitt (1.6%), hairy cell (1.1%), lymphoplasmacytic (1.1%), and NHL not‐otherwise‐specified (10.8%). Over the study period, the proportion of NHL not‐otherwise‐specified declined by half, while marginal zone lymphoma doubled. The distribution of major and rare NHL subtypes varied according to demographics but less so geographically or by type of treatment facility. We noted several novel findings among Hispanics (lower proportion of CLL/SLL, but higher Burkitt lymphoma and nasal NK/T‐cell lymphoma), Asians (higher enteropathy‐associated T‐cell and angioimmunoblastic T‐cell lymphomas), Blacks (higher hepatosplenic T‐cell lymphoma), and Native Americans (similar proportions of CLL/SLL and nasal NK/T‐cell lymphoma as Asians). With the exception of peripheral T‐cell not‐otherwise‐specified and hairy cell leukemia, 5‐year OS has improved for all the major NHL subtypes. Am. J. Hematol. 90:790–795, 2015. © 2015 Wiley Periodicals, Inc.
Femoral Strength Changes Faster With Age Than BMD in Both Women and Men: A Biomechanical Study
Rezaei, Asghar, Dragomir‐Daescu, Dan , Rezaei, Asghar

Journal of Bone and Mineral Research | June 19, 2015 | Volume: 30 | Issue: 12 | Pages: 2200-2206

10.1002/jbmr.2572 | PMID 26096829 Get It

ABSTRACT Although a large number of studies have addressed the age-related changes in bone mineral density (BMD), there is a paucity of data for the assessment of femoral strength loss with age in both genders. We determined the variation of strength with age in femurs of women and men by mechanical tests on a cohort of 100 cadaveric femurs. In addition, the age-related neck BMD loss in our cadaveric cohort was found to be similar with BMD loss of four published population-based studies. Given the strong correlation found in our cadaveric study between BMD and femoral strength, we also estimated the femoral strength of the four populations based on their reported neck BMDs. Our study showed that men's femurs in our cadaveric cohort were stronger than women's femurs by about 800 N at the same BMD level, and by 1750 N at the same age. The strength differences were not explained satisfactorily by the size difference between men's and women's bones. Similar to the findings of clinical studies, the BMD values of men at all ages were larger than that of women. The age-related loss rates in BMD and strength were not statistically different between the two genders of our cadaveric cohort. After normalization, strength decreased more than 40% faster than BMD. On average, men reached a certain BMD value about 16 years later than women, and for strength about 23 years later, which may explain the higher rate of hip fracture in postmenopausal women. In patient population cohorts men reached a similar BMD value about 16 to 25 years later than women, whereas for estimated strength, sometimes more than 40 years later. © 2015 American Society for Bone and Mineral Research.
Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study
Carlson, Matthew L. , Tveiten, Øystein Vesterli , Driscoll, Colin L. W., Sullan, Molly J., Goplen, Frederik Kragerud , Lund‐Johansen, Morten , Link, Michael J. , Boes, Christopher J.

Journal of Neurosurgery | June 19, 2015 | Volume: 123 | Issue: 5 | Pages: 1276-1286

10.3171/2014.12.jns142109 | PMID 26090830 Get It

OBJECT The primary goals of this study were: 1) to examine the influence of disease and treatment on headache in patients with sporadic vestibular schwannoma (VS); and 2) to identify clinical predictors of long-term headache disability. METHODS This was a cross-sectional observational study with international multicenter enrollment. Patients included those with primary sporadic < 3-cm VS and a separate group of general population control subjects without tumors. Interventions included a postal survey incorporating the Headache Disability Inventory (HDI), the Hospital Anxiety and Depression Scale, and a VS symptom questionnaire. The main outcome measures were univariate and multivariable associations with HDI total score. RESULTS The overall survey response rate was 79%. Data from 538 patients with VS were analyzed. The mean age at time of survey was 64 years, 56% of patients were female, and the average duration between treatment and survey was 7.7 years. Twenty-seven percent of patients received microsurgery, 46% stereotactic radiosurgery, and 28% observation. Patients with VS who were managed with observation were more than twice as likely to have severe headache disability compared with 103 control subjects without VS. When accounting for baseline differences, there was no statistically significant difference in HDI outcome between treatment modalities at time of survey. Similarly, among the microsurgery cohort, the long-term risk of severe headache disability was not different between surgical approaches. Multivariable regression demonstrated that younger age, greater anxiety and depression, and a preexisting diagnosis of headache were the primary predictors of severe long-term headache disability, while tumor size and treatment modality had little influence. CONCLUSIONS At a mean of almost 8 years following treatment, approximately half of patients with VS experience headaches of varying frequency and severity. Patient-driven factors including age, sex, mental health, and preexisting headache syndrome are the strongest predictors of long-term severe headache disability. Tumor size and treatment modality have less impact. These data may assist with patient counseling regarding long-term expectations following diagnosis and treatment.
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin‐4 channelopathies: a decade later
Pittock, Sean J. , Lucchinetti, Claudia F. , Pittock, S J

Annals of the New York Academy of Sciences | June 19, 2015 | Volume: 1366 | Issue: 1 | Pages: 20-39

10.1111/nyas.12794 | PMID 26096370 Get It

The discovery of AQP4‐IgG (a pathogenic antibody that targets the astrocytic water channel aquaporin‐4), as the first sensitive and specific biomarker for any inflammatory central nervous system demyelinating disease (IDD), has shifted emphasis from the oligodendrocyte and myelin to the astrocyte as a central immunopathogenic player. Neuromyelitis optica (NMO) spectrum disorders (SDs) represent an evolving spectrum of IDDs extending beyond the optic nerves and spinal cord to include the brain (especially in children) and, rarely, muscle. NMOSD typical brain lesions are located in areas that highly express the target antigen, AQP4, including the circumventricular organs (accounting for intractable nausea and vomiting) and the diencephalon (accounting for sleep disorders, endocrinopathies, and syndrome of inappropriate antidiuresis). Magnetic resonance imaging brain abnormalities fulfill Barkoff criteria for multiple sclerosis in up to 10% of patients. As the spectrum broadens, the importance of highly specific assays that detect pathogenic AQP4‐IgG targeting extracellular epitopes of AQP4 cannot be overemphasized. The rapid evolution of our understanding of the immunobiology of AQP4 autoimmunity necessitates continuing revision of NMOSD diagnostic criteria. Here, we describe scientific advances that have occurred since the discovery of NMO‐IgG in 2004 and review novel targeted immunotherapies. We also suggest that NMOSDs should now be considered under the umbrella term autoimmune aquaporin‐4 channelopathy .
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Yang, Ju Dong , Campion, Michael B., Liu, Minetta C. , Chaiteerakij, Roongruedee , Giama, Nasra H., Mohammed, Hager Ahmed, Hu, Chunling , Campion, Victoria, Jen, Jin , Venkatesh, Sudhakar K. , Halling, Kevin C. , Kipp, Benjamin R. , Roberts, Lewis R. , Ahmed Mohammed, Hager, Campion, Victoria L, Yang, Ju Dong , Chaiteerakij, Roongruedee , Zhang, Xiaodan , Roberts, Lewis R , Venkatesh, Sudhakar K , Hu, Chunling

Hepatology | June 19, 2015 | Volume: 63 | Issue: 1 | Pages: 148-158

10.1002/hep.27944 | PMID 26096702 Get It

Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA). Eighty‐eight patients with CCA were prospectively enrolled at Mayo Clinic Rochester between June 2010 and September 2014. The CellSearch system by Veridex was used for detection of CTCs in peripheral blood. Associations between CTC, patient and tumor characteristics, and survival were examined using the Cox's proportional hazards model. Fifteen patients (17%) were positive for CTC ≥2 and 8 patients (9%) for CTC ≥5. CTCs were associated with tumor extent. CTC ≥2 (hazard ratio [HR]: 2.5; 95% confidence interval [CI]: 1.1‐5.4; P = 0.02) and CTC ≥5 (HR, 4.1; 95% CI: 1.4‐10.8; P = 0.01) were both independent predictors of survival. In subgroup analyses, CTC ≥2 (HR, 8.2; 95% CI: 1.8‐57.5; P < 0.01) and CTC ≥5 (HR, 7.7; 95% CI: 1.4‐42.9; P = 0.02) were both associated with shorter survival among patients with metastasis. There was a trend toward association of CTC ≥5 with shorter survival in patients with nonmetastatic CCA (HR, 4.3; 95% CI: 1.0‐13.8; P = 0.06). CTC ≥2 (HR, 10.5; 95% CI: 2.2‐40.1; P < 0.01) and CTC ≥5 (HR, 10.2; 95% CI: 1.5‐42.3; P = 0.02) were both associated with shorter survival among patients with perihilar/distal CCA. CTC ≥5 was associated with shorter survival of patients with intrahepatic CCA (HR, 4.2; 95% CI: 1.1‐14.1; P = 0.04). Conclusion: CTCs were associated with more‐aggressive tumor characteristics and independently associated with survival in patients with CCA. Assessment of CTCs may be useful for identifying CCA patients at risk of early mortality. (Hepatology 2016;63:148–158)
Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses
Tabayoyong, William, Abouassaly, Robert , Kiechle, Jonathan, Cherullo, Edward E., Meropol, Neal J. , Shah, Nilay D. , Dong, Shan , Thompson, R. Houston, Smaldone, Marc C. , Zhu, Hui , Ialacci, Sarah, Kim, Simon P. , Dong, Shan

Journal of Urology | June 19, 2015 | Volume: 194 | Issue: 6 | Pages: 1548-1553

10.1016/j.juro.2015.06.076 | PMID 26094808 Get It

Osteocalcin and type 2 diabetes risk in Latinos: A life course approach.
Gonzalez-Garcia, Zoe, Mandarino, Lawrence J. , Shaibi, Gabriel Q. , Kullo, Iftikhar J. , Coletta, Dawn K.

American Journal of Human Biology | June 19, 2015 | Volume: 27 | Issue: 6 | Pages: 859-861

10.1002/ajhb.22745 | PMID 26088710 Get It

ObjectiveTo examine associations between circulating levels of the bone‐derived protein osteocalcin (OC) and type 2 diabetes (T2D) risk in Latino children and adults.MethodsSerum OC was measured in 136 children and 531 adults who had the following T2D risk factors assessed, body mass index (BMI), Hemoglobin A1c (HbA1c), fasting and 2‐hour glucose during an oral glucose tolerance test.ResultsOC was significantly higher in children than adults (209.0 ± 12.1 vs. 41.0 ± 0.9 ng/ml, p<0.0001). In adults, OC was inversely associated (all p<0.001) with BMI (r=‐0.2), HbA1c (r=‐0.2), fasting glucose (r=‐0.16), and 2‐hour glucose (r=‐0.21), while there were no significant associations in children. There was a stepwise decrease in OC with increasing dysglycemia in adults, normoglycemic (44.1 ± 1.3 ng/ml), prediabetic (39.3 ± 1.3 ng/ml), and T2D (31.8 ± 1.2 ng/ml), (p<0.0001), whereas there were no differences between normal and prediabetic youth (195.7 ± 16.1 vs. 194.7 ± 25.8 ng/ml, p=0.3).ConclusionsOC was inversely associated with T2D risk in Latino adults; however, this pattern was not observed in children. Am. J. Hum. Biol. 27:859–861, 2015. © 2015 Wiley Periodicals, Inc.
Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans
Carty, Cara L. , Keene, Keith L. , Cheng, Yu-Ching , Chen, Wei‐Min , Nalls, Mike A., Bis, Joshua C. , Kittner, Steven J. , Rich, Stephen S. , Tajuddin, Salman M. , Zonderman, Alan B. , Evans, Michele K. , Langefeld, Carl D. , Gottesman, Rebecca F., Shahar, Eyal , Woo, Daniel , Yaffe, Kristine , Sale, Michèle M. , Dichgans, Martin , Longstreth, W. T., Mitchell, Braxton D. , Reiner, Alex P. , Worrall, Bradford B. , Fornage, Myriam , Nalls, Mike, Tajuddin, Salman, Reiner, Alexander, Meschia, James F. , Mosley, Thomas H. , Liu, Ching‐Ti , Malik, Rainer , Psaty, Bruce M. , Kooperberg, Charles , Dichgans, Martin , Rich, Stephen S , Mitchell, Braxton D

Stroke | June 18, 2015 | Volume: 46 | Issue: 8 | Pages: 2063-2068

10.1161/strokeaha.115.009044 | PMID 26089329 Get It

Background and Purpose— The majority of genome-wide association studies (GWAS) of stroke have focused on European-ancestry populations; however, none has been conducted in African Americans, despite the disproportionately high burden of stroke in this population. The Consortium of Minority Population Genome-Wide Association Studies of Stroke (COMPASS) was established to identify stroke susceptibility loci in minority populations. Methods— Using METAL, we conducted meta-analyses of GWAS in 14 746 African Americans (1365 ischemic and 1592 total stroke cases) from COMPASS, and tested genetic variants with P <10 −6 for validation in METASTROKE, a consortium of ischemic stroke genetic studies in European-ancestry populations. We also evaluated stroke loci previously identified in European-ancestry populations. Results— The 15q21.3 locus linked with lipid levels and hypertension was associated with total stroke (rs4471613; P =3.9×10 −8 ) in African Americans. Nominal associations ( P <10 −6 ) for total or ischemic stroke were observed for 18 variants in or near genes implicated in cell cycle/mRNA presplicing ( PTPRG , CDC5L ), platelet function ( HPS4 ), blood–brain barrier permeability ( CLDN17 ), immune response ( ELTD1, WDFY4 , and IL1F10-IL1RN ), and histone modification ( HDAC9 ). Two of these loci achieved nominal significance in METASTROKE: 5q35.2 ( P =0.03), and 1p31.1 ( P =0.018). Four of 7 previously reported ischemic stroke loci ( PITX2, HDAC9, CDKN2A/CDKN2B , and ZFHX3 ) were nominally associated ( P <0.05) with stroke in COMPASS. Conclusions— We identified a novel genetic variant associated with total stroke in African Americans and found that ischemic stroke loci identified in European-ancestry populations may also be relevant for African Americans. Our findings support investigation of diverse populations to identify and characterize genetic risk factors, and the importance of shared genetic risk across populations.
Key Controversies in Colloid and Crystalloid Fluid Utilization
Frazee, Erin N., Leedahl, David D. , Frazee, Erin N., Kashani, Kianoush

Hospital Pharmacy | June 18, 2015 | Volume: 50 | Issue: 6 | Pages: 446-453

10.1310/hpj5006-446 | PMID 26405334 Get It

Nearly 2 centuries have passed since the use of intravenous fluid became a foundational component of clinical practice. Despite a steady stream of published investigations on the topic, questions surrounding the choice, dose, timing, targets, and cost-effectiveness of various fluid options remain insufficiently answered. In recent years, 2 of the most debated topics reference the role of albumin in acute care and the safety of normal saline. Although albumin has a place in therapy for specific patient populations, its high cost relative to other fluids makes it a less desirable option for hospitals and health systems with escalating formulary scrutiny. Pharmacists bear responsibility for reconciling this disparity and supporting the rational use of albumin in acute care through a careful evaluation of recently published literature. In parallel, it has become clear that crystalloids should no longer be considered a homogenous class of fluids. The past reliance on normal saline has been questioned due to recent findings of renal dysfunction attributable to the solution's supraphysiologic chloride concentration. These safety concerns with 0.9% sodium chloride may result in a practice shift toward more routine use of “balanced crystalloids,” such as lactated Ringer's or Plasma-Lyte, that mimic the composition of extracellular fluid. The purpose of this review is to summarize the evidence regarding these 2 important fluid controversies that are likely to affect hospital pharmacists in the coming decades — the evidence-based use of human albumin and the rising role of balanced salt solutions in clinical practice.